Literature DB >> 21242820

Hot flashes and carotid intima media thickness among midlife women.

Rebecca C Thurston1, Kim Sutton-Tyrrell, Susan A Everson-Rose, Rachel Hess, Lynda H Powell, Karen A Matthews.   

Abstract

OBJECTIVE: Emerging evidence suggests associations between menopausal hot flashes and cardiovascular risk. However, whether hot flashes are associated with intima media thickness (IMT) or IMT changes over time is unknown. We hypothesized that reported hot flashes would be associated with greater IMT cross-sectionally and with greater IMT progression over 2 years.
METHODS: Participants were 432 women aged 45 to 58 years at baseline participating in the Study of Women's Health Across the Nation (SWAN) Heart, an ancillary study to the SWAN. Measures at the SWAN Heart baseline and follow-up visit 2 years later included a carotid artery ultrasound, reported hot flashes (past 2 weeks: none, 1-5 d, ≥6 d), and a blood sample for measurement of estradiol.
RESULTS: Women reporting hot flashes for 6 days or more in the prior 2 weeks had significantly higher IMT than did women without hot flashes at the baseline (mean [SE] difference, 0.02 [0.01] mm; P=0.03) and follow-up (mean [SE] difference, 0.02 [0.01] mm; P=0.04) visits, controlling for demographic factors and cardiovascular risk factors. Reporting hot flashes at both study visits was associated with higher follow-up IMT relative to reporting hot flashes at neither visit (mean [SE] difference, 0.03 [0.01] mm; P=0.03). Associations between hot flashes and IMT largely remained after adjusting for estradiol. An interaction between hot flashes and obesity status was observed (P=0.05) such that relations between hot flashes and IMT were observed principally among overweight/obese women. Hot flashes were not associated with IMT progression.
CONCLUSIONS: These findings provide some indication that women reporting hot flashes for 6 days or more in the prior 2 weeks may have higher IMT than do women without hot flashes, particularly for women who are overweight or obese. Further work should determine whether hot flashes mark adverse underlying vascular changes.
© 2011 by The North American Menopause Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242820      PMCID: PMC3116932          DOI: 10.1097/gme.0b013e3181fa27fd

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  25 in total

Review 1.  Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.

Authors:  James H Stein; Claudia E Korcarz; R Todd Hurst; Eva Lonn; Christopher B Kendall; Emile R Mohler; Samer S Najjar; Christopher M Rembold; Wendy S Post
Journal:  J Am Soc Echocardiogr       Date:  2008-02       Impact factor: 5.251

2.  The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk.

Authors:  Matthew A Allison; Joann E Manson
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

3.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

4.  Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Karen A Matthews; Laura L Schott; Sarah Brockwell; Nancy E Avis; Howard M Kravitz; Susan A Everson-Rose; Ellen B Gold; MaryFran Sowers; John F Randolph
Journal:  J Affect Disord       Date:  2007-02-28       Impact factor: 4.839

5.  Objective hot flashes are negatively related to verbal memory performance in midlife women.

Authors:  Pauline M Maki; Lauren L Drogos; Leah H Rubin; Suzanne Banuvar; Lee P Shulman; Stacie E Geller
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

6.  Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Rachel P Wildman; Alicia B Colvin; Lynda H Powell; Karen A Matthews; Susan A Everson-Rose; Steven Hollenberg; Janet M Johnston; Kim Sutton-Tyrrell
Journal:  Menopause       Date:  2008 May-Jun       Impact factor: 2.953

7.  Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study.

Authors:  Rebecca C Thurston; Kim Sutton-Tyrrell; Susan A Everson-Rose; Rachel Hess; Karen A Matthews
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

8.  Menopausal complaints are associated with cardiovascular risk factors.

Authors:  Gerrie-Cor M Gast; Diederick E Grobbee; Victor J M Pop; Jules J Keyzer; Colette J M Wijnands-van Gent; Göran N Samsioe; Peter M Nilsson; Yvonne T van der Schouw
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Evidence for a role of hot flushes in vascular function in recently postmenopausal women.

Authors:  Pauliina Tuomikoski; Pia Ebert; Per-Henrik Groop; Petri Haapalahti; Hanna Hautamäki; Mats Rönnback; Olavi Ylikorkala; Tomi S Mikkola
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

10.  Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.

Authors:  Alison J Huang; George F Sawaya; Eric Vittinghoff; Feng Lin; Deborah Grady
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 3.310

View more
  43 in total

1.  Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women.

Authors:  V J Victorino; C Panis; F C Campos; R C Cayres; A N Colado-Simão; S R Oliveira; A C S A Herrera; A L Cecchini; R Cecchini
Journal:  Age (Dordr)       Date:  2012-05-28

2.  Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study.

Authors:  Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2013-12-17       Impact factor: 2.681

Review 3.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

4.  Reproductive endocrinology: menopausal vasomotor symptoms and insulin resistance.

Authors:  Emily D Szmuilowicz
Journal:  Nat Rev Endocrinol       Date:  2012-10-02       Impact factor: 43.330

5.  The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.

Authors:  Laura B Harrington; Marc Blondon; Mary Cushman; Andrew M Kaunitz; Jacques E Rossouw; Matthew A Allison; Lisa W Martin; Karen C Johnson; Jan Rosing; Nancy F Woods; Andrea Z LaCroix; Susan R Heckbert; Barbara McKnight; Nicholas L Smith
Journal:  Menopause       Date:  2017-04       Impact factor: 2.953

6.  Hot Flash Frequency and Blood Pressure: Data from the Study of Women's Health Across the Nation.

Authors:  Elizabeth A Jackson; Samar R El Khoudary; Sybil L Crawford; Karen Matthews; Hadine Joffe; Claudia Chae; Rebecca C Thurston
Journal:  J Womens Health (Larchmt)       Date:  2016-07-12       Impact factor: 2.681

Review 7.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

8.  Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Ping Guo Tepper; Elizabeth A Jackson; Hadine Joffe; Hsiang-Yu Chen; Karen A Matthews
Journal:  Stroke       Date:  2015-11-17       Impact factor: 7.914

9.  Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms.

Authors:  Jennifer L Gordon; David R Rubinow; Rebecca C Thurston; Julia Paulson; Peter J Schmidt; Susan S Girdler
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

10.  Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study.

Authors:  Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary
Journal:  J Clin Lipidol       Date:  2020-07-08       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.